Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine Neuroplasticity in First-Episode Schizophrenia
NCT00554658Phase 4Completed
- Sponsor
- University of Regensburg
- Start
- Mar 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in schizophrenia, sponsored by University of Regensburg. Started Mar 2008; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00554658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554658.